Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Paediatrics
  4. Back
  5. Infectious Disease (Paediatric)
  6. Management of possible rabies exposure in children and young people (1192)
Important: please update your RDS app to version 4.7.3 Details with newsletter below.

Please update your RDS app to v4.7.3

We asked you in January to update to v4.7.2.  After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. 

To update to the latest release:

 On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Right Decision Service newsletter: February 2025

Welcome to the February 2025 update from the RDS team

1.     Next release of RDS

 

A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:

 

  • Fixes to mitigate the recurring glitches with the RDS admin area and the occasional brief user interface outages which have arisen following implementation of the new distributed technology infrastructure in December 2024.

 

  • Capability to embed content from Google calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream into RDS pages.

 

  • Capability to include simple multiplication in RDS calculators.

 

The release will also incorporate a number of small fixes, including:

  • Exporting of form within Medicines Sick Day Guidance in polypharmacy toolkit
  • Links to redundant content appearing in search in some RDS toolkits
  • Inclusion of accordion headers alongside accordion text in search result snippets.
  • Feedback form on mobile app.
  • Internal links on mobile app version of benzo tapering tool

 

We will let you know when the date and time for the new release are confirmed.

 

2.     New RDS developments

There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.

The Benzodiazepine tapering tool is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.

3.     Archiving and version control and new RDS Search and Browse interface

Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.

4.     Statistics

At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .

 

5.     Review of content past its review date

We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.

 

6.     Toolkits in development

Some important toolkits in development by the RDS team include:

  • National CVD prevention pathways – due for release end of March 2025.
  • National respiratory pathways, optimal cancer diagnostic pathways and cancer prehabilitation pathways from the Centre for Sustainable Delivery. We will shortly start work on the national cancer referral pathways, first version due for release via RDS around end of June 2025.
  • HIS Quality of Care Review toolkit – currently in final stages of quality assurance.

 

The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.

 

7. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 28th February 12-1 pm
  • Tuesday 11th March 4-5 pm

 

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

Management of possible rabies exposure in children and young people (1192)

Warning

Objectives

1. This guideline summarises the risk assessment and management of children with possible rabies exposure in line with national guidance, and outlines the pathway for administration of post-exposure treatment for children and young people under 16 years old in NHS Greater Glasgow & Clyde.

Scope

2. This local pathway is intended for use by primary care and emergency department clinicians in NHS Greater Glasgow & Clyde. It applies only to children under 16 years old: older young people should be referred via the adult pathway. Clinicians outwith NHS Greater Glasgow & Clyde should follow national guidance and refer to their own local pathways for post-exposure treatment. This guideline complements but does not replace national guidance in Section 10: Key References.

Rabies virus is transmitted via a bite or scratch from an infected animal. Less often, it can be transmitted through body fluid contact with an open wound or mucous membrane – for example, mouth, nasal cavity or eyes. The virus will not pass through intact skin. The incubation period is usually 3-12 weeks but can vary from a few days to many years. Rabies disease is almost always fatal without pre-exposure prophylaxis or post-exposure treatment.

Most cases of rabies exposure occur abroad. Domestic animals with no travel outside the UK do not present a risk of rabies. However, rabies exposure can occur in the UK after contact with bats or imported animals.  Many common holiday destinations, for example Turkey, have a high risk of rabies in domestic animals, while others have no risk, for example France. A full risk assessment should therefore always be completed.

A focussed history is required, covering:

  • date of exposure
  • country of exposure
  • species and current health status of animal involved
  • details of injuries sustained
  • any treatments to date
  • if the child has had previous rabies immunisations (if yes, see Section 6: Note 1)
  • if the child is immunosuppressed (if possibility, see Section 6: Note 2)
  • if the child has any allergies (if yes, see Section 6: Note 3)
  • if the child has any history of bleeding disorder (if yes, see Section 6: Note 4)

Use this information to complete a risk assessment using the Flow-chart and Tables below.

Rabies risks in terrestrial animals by country - GOV.UK

Table 1 - Category of Exposure

Source: 2023-09-04-rabies-guidance-prep-and-pet-scotland-v2-1pdf.pdf (publichealthscotland.scot)]

Category of exposure

Terrestrial Animals

Bats

Category 1 Exposure

No physical contact with saliva 

For example:

  • touching or stroking animals

No physical contact (i.e. no direct contact with the bat’s saliva)

For example:

  • touching a dead bat
  • touching a bat where the person was protected by a barrier capable of preventing saliva contact, such as a boot, shoe, or appropriate protective clothing
  • a bat in the same room as a person (including a sleeping person) in the UK or Ireland

Category 2 Exposure

Minimal contact with saliva and/or unable to infiltrate wound with HRIG if needed

For example:

  • bruising or abrasions
  • licks to broken skin (i.e. over insect bites or scratches) scratches
  • bites which do not break the skin

Uncertain or potentially unrecognised physical contact (i.e. where there has been no observed direct physical contact (with saliva) but this could have occurred) 

For example:

  • when handling a bat without appropriate protective clothing (e.g. gloves)
  • where a bat becomes tangled in hair
  • where a bat is found in the room of a sleeping person outside of the UK/ Ireland
  • potential contact with a bat in the UK or Ireland in someone who is unable to give an accurate history of an exposure (e.g. intoxicated individual, young child, individual with mental impairment) 

Category 3 Exposure

Direct contact with saliva

For example:

  • severe/deep lacerations (i.e. down to the muscle)
  • bites that break the skin contact with mucous membranes with saliva (for example, licks)

 

Direct physical contact with bat’s saliva

For example:

  • all bites or scratches
  • contamination of mucous membrane with saliva or urine

Table 2: Composite Risk

Table 3: Treatments required

Treatment notes:

  • Most children will be considered non-immunised - see Section 6: Note 1
  • Day 0 is the day of first vaccine, not necessarily the day of exposure
  • Rabies vaccinations are given in the deltoid for children and adolescents, or anterolateral thigh in infants
  • If HRIG indicated, see Section 7: HRIG,

Note 1: immunisation status

Most children will not have had previous rabies immunisations. To be considered fully immunised they would need EITHER:

  • a well documented pre-exposure or post-exposure course of rabies immunisations
  • a recent documented rabies antibody titre of at least 0.5 IU/ml

If in doubt, manage as the child as if they are unimmunised.

Note 2: Immunosuppression

For the purposes of rabies risk assessment, a child should be considered immunosuppressed if they fulfil the criteria for immunosuppression in Annexe 1 of the document linked below:

Guidelines on managing rabies postexposure (UK Health Security Agency, January 2023)

Note 3: Allergies

There are no contraindications to post-exposure treatment with rabies vaccine (including Rabipur for those with severe egg allergies). In the event of a hypersensitivity reaction to a dose of a pre-exposure course, such individuals should still receive post-exposure immunisation if indicated, because the risks of rabies outweigh the risks of hypersensitivity. When there is a history of a hypersensitivity reaction to rabies immunisation, seek advice.

Note 4: Bleeding disorders

If vaccinations are required and the child has a bleeding disorder, if may be more appropriate for these to be given subcutaneously. Seek advice if unsure.

Note 5: Immunisation schedules already started

The risk assessment above should be completed. Where a regime has been started that is different from what would have been used in the UK, advice should be sought from the paediatric ID team in daytime hours (between 9 am and 5 pm), e.g. the following day if out of hours (Section 9: Sources of Advice).

Arranging follow-up immunisations

  • If the patient is in ED, follow-up immunisations should be requested for 1C as per Section 8: Follow-up
  • If the patient is in Primary Care, please contact the ID team in-hours (as per Section 9: Sources of Advice). who will assist in arranging follow-up. Please have the details required for the Risk Assessment to hand.

Note 6: Exposure to recently imported animals

Animals recently imported into the UK may pose a rabies risk. If the animal is in a facility (e.g, zoo), discuss with the responsible veterinary surgeon to determine the risk. If suspicion of illegally imported animal (e.g, domestic dog), discuss with paediatric infectious diseases team.

Patients requiring HRIG should be discussed with the paediatric infectious diseases team.

Note that HRIG is not indicated:

  • More than 7 days after first dose of post-exposure course
  • More than one day after second dose of post-exposure course
  • If exposure over 12 months previous (although vaccine may be indicated)

If required, HRIG should be given in ED:

  • Wound washing is the most important preventative measure:
    • Potentially rabies-exposed wounds should be cleaned immediately and thoroughly with soap or detergent and flushed with running water for 10–15 minutes
    • A virucidal agent such as povidone-iodine solution or 40–70% alcohol should be applied and the wound covered with a simple dressing (not closed)
    • Remember that tetanus prophylaxis may also be required.
  • 20 IU/kg body weight should be infiltrated in and around the cleansed wound

Refer to full guidance on giving HRIG in the Green Book chapter 27: Rabies: the green book, chapter 27 - GOV.UK (www.gov.uk)

Overview

If the patient is resident in the GGC catchment area, subsequent doses of rabies immunisation should be requested to be given on Ward 1C (paediatric day unit).

Please note: GP surgeries are unable to do request or provide these immunisations, so follow-up needs to be requested before discharge from ED.

If the patient is outside the GGC catchment area then subsequent doses should be given by local services as per local arrangements.

Procedure for completing referral to 1C

Please find out the name of the consultant on-call for paediatric infectious diseases – this can be found on Rotawatch or by asking the switchboard operator.

On Trakcare, go to “New Request” → Select “Other” tab → Click the magnifying glass next to “Other” → Use right arrow to find “Paediatric investigation unit ref”):

  • Under “Please arrange…”: State date of exposure, and dates that follow-up rabies vaccination are required
  • Under “Medical review required”: No
  • Under “Name and designation of reviewing doctor”: “If input required, please contact ID service phone: 84939
  • Consultant: name of the on-call paediatric ID consultant
  • Requestors contact details: ID service phone 84939

Once complete, please email the consultant on call for paediatric infectious diseases with name, CHI, and dates of requested vaccinations.

Notes:

  • Please ensure the ED discharge letter contains enough details of the Risk Assessment for the ID team to verify that the child is on the correct immunisation course
  • 1C will contact the family with appointments for subsequent immunisations
  • While in 1C for follow-up vaccinations, patient will be formally under care of ID team
  • A prescription for the immunisations will do done on a paper Kardex by the ID team
  • After the final immunisation, the ID team will dictate a letter to the GP to document the completed course.

More detailed advice on the pathways outlined here is included in national guidance documents, linked in Section 10: Key references.

For patients in ED, for initial advice please discuss with the senior clinician in ED. Further support is also available from the paediatric infectious disease team (Mon-Fri 5pm 84939, out-of-hours consultant on call via switchboard).

For patients presenting to primary care, if in doubt please discuss with the paediatric infectious diseases team as above.

In either case, if a child has already commenced their rabies post-exposure prophylaxis (whether in UK or abroad) and are clinically well, any queries regarding follow-up doses or arrangements should be discussed in-hours the following day rather than out of hours.

Rabies: guidance on pre-exposure and post-exposure measures for humans in Scotland (Public Health Scotland, September 2023)

Guidelines on managing rabies postexposure (UK Health Security Agency, January 2023)

Editorial Information

Last reviewed: 05/03/2025

Next review date: 31/03/2028

Author(s): Nicholas Robertson, Louisa Pollock, Katherine Longbottom.

Version: 1

Author email(s): Louisa.pollock@nhs.scot.

Document Id: 1192